ストックスクリーナーアプリを入手
11.45
3.17%
-0.375
アフターアワーズ：
11.45
0.005
+0.04%
前日終値:
$11.82
開ける：
$11.77
24時間の取引高:
530.17K
Relative Volume:
0.39
時価総額：
$999.69M
収益：
-
当期純損益:
$-185.15M
株価収益率:
-5.651
EPS:
-2.0253
ネットキャッシュフロー:
$-148.72M
1週間 パフォーマンス:
-2.18%
1か月 パフォーマンス:
-8.51%
6か月 パフォーマンス:
-55.50%
1年 パフォーマンス:
+122.67%
1日の値動き範囲:
$11.37
$11.87
1週間の範囲:
$11.02
$12.53
52週間の値動き範囲:
$4.47
$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
11.45 | 1.05B | 0 | -185.15M | -148.72M | -2.0253 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | Wolfe Research | Peer Perform |
| 2026-03-19 | 再開されました | Jefferies | Buy |
| 2026-02-11 | 開始されました | Stifel | Buy |
| 2026-01-07 | 開始されました | Piper Sandler | Overweight |
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-12 | 繰り返されました | Citigroup | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 12,500 Shares of Stock - MarketBeat
Form 4 Olema Pharmaceuticals Inc For: 27 July By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals director Cyrus Harmon sells $291k in stock - Investing.com
Olema Pharmaceuticals Inc (OLMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Olema Pharmaceuticals Inc (OLMA) Cash Flow - TradingKey
OLMA|Olema Pharmaceuticals Inc|Price:11.470|Chg%:-0.540 - TradingKey
OLMA|Olema Pharmaceuticals Inc|Price:12.020|Chg%:+0.320 - TradingKey
Olema Pharmaceuticals Inc (OLMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Olema Pharmaceuticals Inc (OLMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Olema Pharmaceuticals (NASDAQ:OLMA) Downgraded by Wall Street Zen to "Strong Sell" - MarketBeat
Form 144 Olema Pharmaceuticals For: 24 July By Investing.com - Investing.com South Africa
Olema Pharmaceuticals launches recruitment drive for medical science liaison role - Traders Union
OLMA (NASDAQ: OLMA) insider plans Rule 144 sale of 12,500 common shares - Stock Titan
Siren L.L.C. Boosts Stake in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. SEC Filing (Jul 23, 2026) - Stock Titan
339,461 Shares in Olema Pharmaceuticals, Inc. $OLMA Bought by SEB Asset Management AB - MarketBeat
OLMA Sees Early Tumor Shrinkage in Phase 1 OP-3136 Study, Stock Gains Pre-Market - Stocktwits
Jennison Associates LLC Has $27.17 Million Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 5.9%Here's Why - MarketBeat
Olema Pharmaceuticals appoints Brad Lanoue as vice president of market access - Traders Union
LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24 - Moomoo
Wall Street Zen Upgrades Olema Pharmaceuticals (NASDAQ:OLMA) to "Sell" - MarketBeat
Enterprise value to EBIT forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Price to earnings forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Price to earnings forward of Olema Pharmaceuticals, Inc. – BOATS:OLMA - TradingView
Price to book forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Olema Pharmaceuticals (OLMA) Jefferies London Healthcare Conference 2025 Summary - Quartr
OLMA News | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill
Enterprise value to EBITDA forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Enterprise value to EBITDA forward of Olema Pharmaceuticals, Inc. – BOATS:OLMA - TradingView
Enterprise value to revenue forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Price to sales forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Olema Pharmaceuticals (OLMA) Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesInvestor Earnings Call - dars.gov.et
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals (OLMA) Q1 2026 Earnings: EPS Beats Estimates Amid Continued R&D ProgressEnergy Earnings Report - DonanımHaber
Olema Pharmaceuticals opens director clinical science role to advance cancer trial programs - Traders Union
Olema Pharmaceuticals (OLMA) Is Up 22.0% After Broad Russell Growth Index InclusionHas The Bull Case Changed? - simplywall.st
Does Olema Pharmaceuticals' (OLMA) Broad Russell Growth Inclusion Reveal a Turning Point in Its Investor Story? - Yahoo Finance
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS: OLMA) added to Russell 2500 Growth Benchmark - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS: OLMA) added to Russell 2000 Growth Benchmark - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to Russell 3000E Growth Benchmark - marketscreener.com
Olema Pharmaceuticals (OLMA) Holds Steady Near Support Amid Minor DeclineUp Down Volume - dars.gov.et
Olema Pharmaceuticals (OLMA) Holds Steady Near Support After Minor DeclineHidden Order - dars.gov.et
Olema Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:OLMA) - TradingView
OLMA Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Olema Pharmaceuticals Inc For: 23 June By Investing.com - Investing.com Australia
Olema (NASDAQ: OLMA) awards director 29,500 stock options - Stock Titan
BVF group (NASDAQ: OLMA) reports 29,500 new options and large pre-funded warrants - Stock Titan
Olema (NASDAQ: OLMA) director receives grant of 29,500 stock options at $9.51 - Stock Titan
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
Olema Pharmaceuticals Inc (OLMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus | Director |
Jul 23 '26 |
Sale |
11.58 |
12,500 |
144,738 |
715,270 |
2.44%
0.02%
大文字化:
|
ボリューム (24 時間):